OSO-Test

A non-invasive and fast test for the assessment of Osteosarcopenic Obesity Syndrome

OSO-Test is an application of BIA-ACC device, PPG device and BioTekna® PLUS

PEARSON’S CORRELATION COEFFICIENTS BETWEEN BIA-ACC AND DEXA

References:

Bioimpedance analysis vs. DEXA as a screening tool for osteosarcopenia in lean, overweight and obese Caucasian postmenopausal females. Hormones 16(2):181-193. 2017.
Sports performance: MUS, Stress and Chronic Low- grade Inflammation. EWF Scientific Magazine N7. 46-55.
Healthy Overweight/Obese Youth: Early Osteosarcopenic Obesity Features. Eur J Clin Invest. 46(9):767-68. 2016.
Increased extracellular water measured by bioimpedance and by increased serum levels of atrial natriuretic peptide in RA patients-signs of volume overload. Clin Rheumatol. 36: 1041-1051. 2016.
The Origin of Chronic Inflammatory Systemic Diseases and their Sequelae. 2015
Stress And Inflammatory Biomarkers And Symptoms Are Associated With Bio-Impedance Measures. Eur J Clin Invest. 45(2):126-34. 2014.

This site is registered on wpml.org as a development site.